| |
| Device | PearlMatrix™ Bone Graft |
|---|
| Generic Name | Filler, bone void, synthetic peptide |
|---|
| Applicant | Cerapedics, Inc.
11025 Dover Street, Suite 1600
Westminster, CO 80021 |
|---|
| PMA Number | P240001 |
|---|
| Date Received | 01/02/2024 |
|---|
| Decision Date | 06/18/2025 |
|---|
| Product Code |
NOX |
| Advisory Committee |
Orthopedic |
|---|
| Clinical Trials | NCT03438747
|
|---|
| Expedited Review Granted? | No |
|---|
| Combination Product | Yes |
|---|
| Predetermined Change Control Plan Authorized | No |
|---|
Approval Order Statement
PearlMatrix™ Bone Graft is indicated for intervertebral body fusion of the spine in skeletally mature patients. PearlMatrix™ Bone Graft is intended to be used in conjunction with a PEEK TLIF Fusion Device and supplemental internal spinal fixation systems cleared by the FDA for use in the lumbosacral spine. The system is to be used in patients who have had at least six months of non-operative treatment. PearlMatrix™ Bone Graft is intended for use at one level in the lumbar spine (L2-S1) for the treatment of degenerative disc disease (DDD) with up to Grade I spondylolisthesis. DDD is defined as back and/or radicular pain of discogenic origin with degeneration of the disc confirmed by history, physical exam, and radiographic studies. |
| Approval Order | Approval Order |
|---|
| Summary | Summary of Safety and Effectiveness |
|---|
| Labeling | Labeling
Labeling Part 2 |
|---|
|
|
